CD8A and neoplasm: The increased infiltration of CD8+ T cells as a consequence of the degradation of HA by PEGPH20 also improved the efficacy of anti-PD-L1 in HA-rich breast cancer tumor models, resulting in inhibition of tumor growth, in comparison with PEGPH20 or anti-PD-L1 alone [168].